TrialHaematologica2018

Plerixafor enables safe, rapid, efficient mobilization of hematopoietic stem cells in sickle cell disease patients after exchange transfusion.

Chantal Lagresle-Peyrou et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.